Target Price | $398.84 |
Price | $346.03 |
Potential | 15.26% |
Number of Estimates | 42 |
42 Analysts have issued a price target Visa 2026 . The average Visa target price is $398.84. This is 15.26% higher than the current stock price. The highest price target is $446.25 28.96% , the lowest is $297.50 14.03% . | |
A rating was issued by 48 analysts: 38 Analysts recommend Visa to buy, 10 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2026 of 15.26% . Most analysts recommend the Visa stock at Purchase. |
41 Analysts have issued a sales forecast Visa 2025 . The average Visa sales estimate is $40.3b . This is 7.13% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $42.0b 11.64% , the lowest is $38.3b 1.73% .
This results in the following potential growth metrics:
2024 | $35.9b | 10.02% |
---|---|---|
2025 | $40.3b | 12.19% |
2026 | $44.5b | 10.36% |
2027 | $48.9b | 9.93% |
2028 | $55.9b | 14.33% |
33 Analysts have issued an Visa EBITDA forecast 2025. The average Visa EBITDA estimate is $28.2b . This is 7.74% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $30.3b 15.90% , the lowest is $25.8b 1.29% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $25.1b | 9.71% |
---|---|---|
2025 | $28.2b | 12.28% |
2026 | $31.4b | 11.52% |
2027 | $34.6b | 10.18% |
2028 | $39.3b | 13.40% |
2029 | $42.5b | 8.33% |
2024 | 69.84% | 0.28% |
---|---|---|
2025 | 69.90% | 0.08% |
2026 | 70.64% | 1.06% |
2027 | 70.79% | 0.21% |
2028 | 70.22% | 0.81% |
43 Visa Analysts have issued a net profit forecast 2025. The average Visa net profit estimate is $24.6b . This is 25.45% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $25.6b 30.48% , the lowest is $23.4b 19.33% .
This results in the following potential growth metrics and future Net Margins:
2024 | $19.5b | 14.53% |
---|---|---|
2025 | $24.6b | 26.65% |
2026 | $27.7b | 12.23% |
2027 | $31.3b | 13.01% |
2028 | $36.3b | 16.29% |
2029 | $40.7b | 12.11% |
2024 | 54.16% | 4.09% |
---|---|---|
2025 | 61.14% | 12.89% |
2026 | 62.18% | 1.70% |
2027 | 63.92% | 2.80% |
2028 | 65.02% | 1.72% |
43 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is $11.56 . This is 16.06% higher than earnings per share in the financial year 2024. The highest EPS forecast is $12.02 20.68% , the lowest is $10.99 10.34% .
This results in the following potential growth metrics and future valuations:
2024 | $9.58 | 17.69% |
---|---|---|
2025 | $11.56 | 20.67% |
2026 | $12.97 | 12.20% |
2027 | $14.66 | 13.03% |
2028 | $17.05 | 16.30% |
2029 | $19.11 | 12.08% |
Current | 34.74 | 12.10% |
---|---|---|
2025 | 29.94 | 13.82% |
2026 | 26.67 | 10.92% |
2027 | 23.60 | 11.51% |
2028 | 20.30 | 13.98% |
2029 | 18.10 | 10.84% |
Based on analysts' sales estimates for 2025, the Visa stock is valued at an EV/Sales of 16.82 and an P/S ratio of 16.65 .
This results in the following potential growth metrics and future valuations:
Current | 18.02 | 11.10% |
---|---|---|
2025 | 16.82 | 6.64% |
2026 | 15.24 | 9.39% |
2027 | 13.87 | 9.03% |
2028 | 12.13 | 12.53% |
Current | 17.84 | 10.57% |
---|---|---|
2025 | 16.65 | 6.66% |
2026 | 15.09 | 9.39% |
2027 | 13.72 | 9.03% |
2028 | 12.00 | 12.53% |
Analyst | Rating | Action | Date |
---|---|---|---|
Mizuho |
Neutral
➜
Outperform
|
Upgrade | Jun 05 2025 |
Truist Securities |
➜
Buy
|
Initiated | Jun 02 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | May 28 2025 |
Jefferies |
Buy
➜
Buy
|
Unchanged | May 27 2025 |
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Apr 30 2025 |
Macquarie |
Outperform
➜
Outperform
|
Unchanged | Apr 30 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 30 2025 |
Analyst Rating | Date |
---|---|
Upgrade
Mizuho:
Neutral
➜
Outperform
|
Jun 05 2025 |
Initiated
Truist Securities:
➜
Buy
|
Jun 02 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
May 28 2025 |
Unchanged
Jefferies:
Buy
➜
Buy
|
May 27 2025 |
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Apr 30 2025 |
Unchanged
Macquarie:
Outperform
➜
Outperform
|
Apr 30 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 30 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.